Diane V. Havlir, MD
Diane V. Havlir, MD, is chief of the HIV/AIDS division and Positive Health Program at San Francisco General Hospital and professor of medicine at the University of California, San Francisco (UCSF). She has worked as a researcher and clinician in the HIV epidemic for over 20 years. After earning her MD degree at Duke University Medical School in 1984, she began her medical career as an intern and resident in internal medicine at UCSF.
Dr. Havlir spearheaded early studies of opportunistic infection treatment and prophylaxis and conducted pivotal studies on nevirapine viral dynamics, antiretroviral therapeutic strategies, and HIV drug resistance. At UCSF, she is the principal investigator of the AIDS Clinical Trials Group, director of the HIV Translational Research Training Program, and director of ASPIRE, a program to build capacity for HIV care in Africa. She also currently directs several antiretroviral trials evaluating novel strategies for the treatment of HIV and co-infections (tuberculosis and malaria). Dr. Havlir’s research accomplishments were recognized recently when she received the HIV Research Achievement Award of the Infectious Diseases Society of America and HIV Medicine Association.
Dr. Havlir was elected to the American Society for Clinical Investigation and is a member of the World Health Organization (WHO) HIV Treatment Guidelines Committee and a founding member of the WHO International HIV Drug Surveillance Program. She is also on the Governing Council of the International AIDS Society. In 2006, she was elected to chair the TB/HIV Working Group of the WHO Stop TB Partnership. She is also the scientific co-chair for the Vienna International AIDS Society 2010 conference.